Literature DB >> 25547622

Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up.

Veronica Silva Vilela1, Sergio Prieto-González, José C Milisenda, Albert Selva-O Callaghan, Josep M Grau.   

Abstract

The aim of the present study was to explore whether polymyositis may be considered as an isolated, organ-specific disease or more suitably as a secondary or associated entity. A retrospective re-evaluation of all the muscle biopsies performed at the Hospital Clínic of Barcelona showing histopathological pattern of polymyositis from January 1997 to May 2012 was carried out. The medical records of the patients with the aforementioned pathological pattern were also reviewed. From 1.290 muscle biopsies performed during the period evaluated, 36 with polymyositis pattern were identified. At the time of muscle biopsy, polymyositis pattern was secondary or associated with other disease in 26 patients and was classified as isolated in the remaining ten patients. After pathological re-evaluation and long-term clinical follow-up, only one patient remained with this diagnosis. Overall, the main final diagnosis related to the initial polymyositis pattern was inflammatory myopathy associated with connective tissue disease. Several other associated conditions were also identified. Isolated polymyositis is highly uncommon. Ruling out potential associated or confusing entities, like inclusion body myositis, overlap syndromes, infections, and cancer, is mandatory.

Entities:  

Mesh:

Year:  2014        PMID: 25547622     DOI: 10.1007/s00296-014-3198-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Unicorns, dragons, polymyositis, and other mythological beasts.

Authors:  Anthony A Amato; Robert C Griggs
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

3.  Polymyositis: not a unicorn or mythological beast...but maybe a duck?

Authors:  John T Kissel
Journal:  Neurology       Date:  2008-02-05       Impact factor: 9.910

4.  Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria.

Authors:  Helen Linklater; Nicolò Pipitone; Michael R Rose; Fiona Norwood; Richard Campbell; Carlo Salvarani; D L Scott; Patrick Gordon
Journal:  Clin Exp Rheumatol       Date:  2013-06-14       Impact factor: 4.473

Review 5.  Inclusion body myositis and myopathies.

Authors:  R C Griggs; V Askanas; S DiMauro; A Engel; G Karpati; J R Mendell; L P Rowland
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

Review 6.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

7.  Polymyositis complicating D-penicillamine treatment.

Authors:  A O Aydintug; R Cervera; D D'Cruz; G Ramírez; R A Asherson; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

8.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.

Authors:  Nizar Chahin; Andrew G Engel
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

9.  [Polymyositis-dermatomyositis: incidence in Spain (1997-2004)].

Authors:  Hernán Vargas-Leguás; Albert Selva-O'Callaghan; Magda Campins-Martí; Eduardo Hermosilla Pérez; Josep M Grau-Junyent; Xavier Martínez Gómez; Josep Vaqué Rafart
Journal:  Med Clin (Barc)       Date:  2007-11-24       Impact factor: 1.725

10.  Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.

Authors:  Carla Fernandez; Nathalie Bardin; André Maues De Paula; Emmanuelle Salort-Campana; Audrey Benyamine; Jérôme Franques; Nicolas Schleinitz; Pierre-Jean Weiller; Jean Pouget; Jean-François Pellissier; Dominique Figarella-Branger
Journal:  Medicine (Baltimore)       Date:  2013-01       Impact factor: 1.889

View more
  4 in total

Review 1.  Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Laís Uyeda Aivazoglou; Rafael Baches Jorge; Edmar Zanoteli; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

2.  DEPTOR-mTOR Signaling Is Critical for Lipid Metabolism and Inflammation Homeostasis of Lymphocytes in Human PBMC Culture.

Authors:  Qi-Bing Xie; Yan Liang; Min Yang; Yuan Yang; Xiao-Min Cen; Geng Yin
Journal:  J Immunol Res       Date:  2017-02-27       Impact factor: 4.818

3.  Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis.

Authors:  Geng Yin; Ying Wang; Xiao-Min Cen; Yuan Yang; Min Yang; Qi-Bing Xie
Journal:  J Immunol Res       Date:  2017-01-17       Impact factor: 4.818

4.  Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.

Authors:  Naohiro Uchio; Kenichiro Taira; Chiseko Ikenaga; Masato Kadoya; Atsushi Unuma; Kenji Yoshida; Setsu Nakatani-Enomoto; Yuki Hatanaka; Yasuhisa Sakurai; Yasushi Shiio; Kenichi Kaida; Akatsuki Kubota; Tatsushi Toda; Jun Shimizu
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.